Fetal heart rate variability recorded at home with INVU, linked to outcomes in toddlers.
Fetal heart rate recorded with INVU to study how maternal distress affects the fetus.
Another manufacturer tested its home device against FDA-cleared INVU as the comparator.
A University of Utah lab used INVU to record fetal and maternal heart rate at home in its own research study.
Names INVU among existing home pregnancy monitors.
Includes the Penn and Sheba INVU studies.
FIGO committee article; cites the INVU contraction study among emerging wearable tocometers.
Names the FDA-cleared INVU belt as a wearable that records heart rates and uterine activity for remote review.
International expert report that lists INVU among fetal monitoring technologies moving into patients’ homes.
Lists INVU as an FDA-cleared fetal ECG device for home monitoring.
Describes INVU and its high correlation with CTG.
National Academy of Engineering journal; describes INVU and its FDA clearances for remote pregnancy monitoring.
Cites INVU as an FDA-cleared abdominal band for fetal and maternal heart rate.
Systematic review of home fetal monitors that includes INVU.
Sheba Beyond describes how it designed a hybrid hospital-and-home unit for high-risk pregnancy, using INVU by Nuvo for fetal heart tracing at home.
Read the highlight →
Sheba Medical Center ran a hybrid programme for women with gestational diabetes, with INVU for the nonstress test at home.
Read the highlight →
Penn researchers asked patients who did their nonstress tests at home with INVU how it went, through weekly surveys and interviews.
Read the highlight →
A Banner Health clinician wrote to the journal about a year of remote nonstress testing with INVU in rural care.
Read the highlight →
At Penn Medicine, 34 patients with high-risk pregnancies enrolled and 29 did their nonstress tests at home with INVU.
Read the highlight →
An independent review of remote fetal monitoring in the COVID-19 era describes INVU among the new technologies.
Read the highlight →
INVU’s contraction monitoring was tested in 118 women (78 in the validation phase) against the intrauterine pressure catheter, the clinical reference.
Read the highlight →
INVU derives uterine activity from the mother’s heart signals, electrical and acoustic, rather than from a pressure belt.
Read the highlight →
In 147 pregnant women, fetal and maternal heart rates recorded with INVU were compared with standard cardiotocography (CTG).
Read the highlight →More about INVU™ beyond the published research.
Whether you would like to know more about INVU™, explore a research collaboration, or partner with us, we would love to hear from you.
Email info@nuvocares.com ↗